Literature DB >> 19111646

Expression of the bacterial hemoglobin gene from Vitreoscilla stercoraria increases rifamycin B production in Amycolatopsis mediterranei.

Guerra Priscila1, Francisco J Fernández, Angel E Absalón, Ma del Rocío Suarez, Mara Sainoz, Javier Barrios-González, Armando Mejía.   

Abstract

It is well known that the culture for rifamycin B production by Amycolatopsis mediterranei requires high levels of dissolved oxygen, particularly in industrial processes. In this study, we report the construction of a vector for the expression of the bacterial hemoglobin gene (vhb) from Vitreoscilla stercoraria in a rifamycin B-overproducing strain of A. mediterranei. The effect was evaluated in the presence and absence of barbital. The vhb gene was cloned under the control of the PermE promoter, the Amycolatopsis lactamdurans plasmid pULVK2 origin of replication, the kanamycin-resistant gene (Km), the erythromycin-resistant gene (ermE) for selection, and ColE1. Industrial fermentation conditions were simulated in shake-flask cultures. Under low aeration, the transformed A. mediterranei strain with the vhb gene showed a 13.9% higher production of rifamycin B in a culture with barbital compared with the parental strain, and 29.5% higher production under the same conditions without barbital.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111646     DOI: 10.1263/jbb.106.493

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  2 in total

1.  Improving rifamycin production in Amycolatopsis mediterranei by expressing a Vitreoscilla hemoglobin (vhb) gene fused to a cytochrome P450 monooxygenase domain.

Authors:  Armando Mejía; Doris Luna; Francisco J Fernández; Javier Barrios-González; Luis H Gutierrez; Ana G Reyes; Angel E Absalón; Steven Kelly
Journal:  3 Biotech       Date:  2018-10-20       Impact factor: 2.406

Review 2.  The aminoshikimic acid pathway in bacteria as source of precursors for the synthesis of antibacterial and antiviral compounds.

Authors:  Adelfo Escalante; Rubén Mendoza-Flores; Guillermo Gosset; Francisco Bolívar
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.